Summary

The global digital twin healthcare market is experiencing significant growth in 2025, driven by the increasing adoption of digital twins in healthcare and rising investments by public & private entities. The market is projected to reach USD 101.19 billion by 2031 from USD 7.47 billion in 2026, at a CAGR of 68.4% during the forecast period. There have been many investments in digital twins by both public and private organizations due to their innovation potential. For instance, Quibim, based in Valencia, is developing the use of imaging biomarkers in precision medicine. Quibim has made an announcement on its successful raising of funds amounting to USD 50.6 million as part of its series A investment round to establish a footprint in the USA market. According to Quibim, this will be a milestone in developing human digital twins. These are dynamic models that will make it possible to monitor the well-being of people while ensuring that drugs are developed efficiently.

https://mnmimg.marketsandmarkets.com/Images/digital-twins-in-healthcare-market2-img-overview.webp

“Surgical planning & medical education segment accounted for the second-largest share of the market during the forecast period, by application.”
In 2025, the surgical planning & medical education segment accounted for the second-largest share of the digital twin in the healthcare market. The growth in this market was driven by the ability of digital twins to work with virtual reality applications that enable the residents to train by simulating surgical processes for the specific anatomical and physiological profile of the patients. This helps in generating a real-life performance depiction and facilitates the evaluation of the intraoperative metrics. Many companies have simulated human anatomy and surgery processes in order to reduce reliance on cadavers.
“By component, software accounted for the fastest growth during the forecast period.”
Based on component, software is projected to witness the fastest growth in the digital twins in healthcare market during the forecast period. The reason behind such growth is associated with the rising number of adoptions of digital twin platforms in order to offer real-time simulation and predictive analytics. In particular, healthcare organizations and research institutions will start relying on software digital twin solutions to develop virtual models of patients, organs, and healthcare facilities based on information collected via imaging techniques, electronic health records, and wearable connected devices. Software digital twin solutions enable not only continuous monitoring but also predicting disease progression and creating personalized treatment plans. Rising interest in digital twin technology and software solutions is also explained by the growing adoption of platforms based on AI and cloud computing. In addition, the rising trend towards value-based care and precision medicine is anticipated to boost demand for digital twin software solutions. Furthermore, the ongoing investments in digital health solutions and the necessity of building interoperable systems capable of interacting with the IT infrastructures of hospitals contribute to such growth.

“Asia Pacific to witness the highest growth rate during the forecast period.”
The market for digital twins in healthcare in the Asia Pacific region is growing at a fast pace, owing to increased clinical research activities and the adoption of digital technologies by healthcare providers. Asia Pacific has emerged as one of the major hubs for research activities, where countries like India, Japan, South Korea, and Australia have become prominent owing to improved regulation and lower cost structure. Pharmaceutical and biotechnology companies are increasingly engaging in research initiatives through the use of data and simulations, which is further driving the adoption of digital twin technologies. At the same time, significant investment is being made towards the development of digital health infrastructure in the form of artificial intelligence, cloud computing, and health IT systems, which are vital for the implementation of digital twin technologies. Furthermore, governments in the Asia Pacific region are working towards the digitalization of the healthcare industry to improve efficiency and performance. There have been recent developments in this regard. For example, the Japanese company Fujitsu Limited has developed digital twin technology in the healthcare sector using artificial intelligence-based simulation platforms for personalized medicine and decision-making in clinical processes.
The breakdown of primary participants is as follows:
? By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
? By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
? By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
The key players operating in the digital twin in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Syst?mes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).
? The study includes an in-depth competitive analysis of these key players in the digital twin in healthcare market, with their company profiles, recent developments, and key market strategies.

Research Coverage
The report analyzes the digital twins in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on components, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to buy this report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.
This report provides insights into:
? Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the digital twins in healthcare market
? Market Development: Comprehensive information on the lucrative emerging markets, components, applications, end users, and regions
? Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the digital twins in healthcare market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market like Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Syst?mes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 28
1.3.2 INCLUSIONS & EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 30
1.5 SUMMARY OF CHANGES 30
2 EXECUTIVE SUMMARY 31
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 31
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 32
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 33
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 34
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 35
3 PREMIUM INSIGHTS 36
3.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW 36
3.2 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT & REGION 37
3.3 DIGITAL TWINS IN HEALTHCARE MARKET: REGIONAL SNAPSHOT 37
4 MARKET OVERVIEW 38
4.1 INTRODUCTION 38
4.2 MARKET DYNAMICS 39
4.2.1 DRIVERS 39
4.2.1.1 Increasing investments by public and private entities 39
4.2.1.2 Growing applications of digital twins 40
4.2.1.3 Technological advancements 40
4.2.1.4 Growing funding and investments in digital twin startups 41
4.2.2 RESTRAINTS 41
4.2.2.1 Managing data quality, privacy issues, and high implementation costs 41
4.2.3 OPPORTUNITIES 42
4.2.3.1 Increasing focus on cutting-edge real-time data analytics 42
4.2.3.2 Growing importance of digital twins in emerging economies 42
?
4.2.4 CHALLENGES 43
4.2.4.1 Lack of skilled professionals 43
4.2.4.2 Integration with existing systems and outdated digital infrastructure 43
4.3 UNMET NEEDS AND WHITE SPACES 44
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 44
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 45
5 INDUSTRY TRENDS 46
5.1 PORTER’S FIVE FORCES ANALYSIS 46
5.1.1 INTENSITY OF COMPETITIVE RIVALRY (HIGH) 47
5.1.2 BARGAINING POWER OF SUPPLIERS (LOW) 47
5.1.3 BARGAINING POWER OF BUYERS (HIGH) 47
5.1.4 THREAT OF NEW ENTRANTS (LOW) 48
5.1.5 THREAT OF SUBSTITUTES (LOW) 48
5.2 MACROECONOMIC INDICATORS 48
5.2.1 INTRODUCTION 48
5.2.2 GDP TRENDS AND FORECAST 48
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 49
5.3 VALUE CHAIN ANALYSIS 49
5.3.1 RESEARCH & PRODUCT DEVELOPMENT 50
5.3.2 TECHNOLOGY INPUTS AND INFRASTRUCTURE 51
5.3.3 PLATFORM DEVELOPMENT AND INTEGRATION 51
5.3.4 DISTRIBUTION 51
5.3.5 MARKETING AND SALES 51
5.3.6 POST-SALE SERVICES 51
5.4 ECOSYSTEM ANALYSIS 51
5.5 PRICING ANALYSIS 53
5.5.1 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY TYPE (2025) 53
5.5.2 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY REGION (2025) 54
5.6 KEY CONFERENCES AND EVENTS, 2026?2027 55
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55
5.8 INVESTMENT AND FUNDING SCENARIO 56
5.9 CASE STUDY ANALYSIS 57
5.10 IMPACT OF 2025 US TARIFF ? DIGITAL TWIN IN HEALTHCARE MARKET 58
5.10.1 INTRODUCTION 58
5.10.2 KEY TARIFF RATES 59
5.10.3 PRICE IMPACT ANALYSIS 59
5.10.4 IMPACT ON COUNTRY/REGION 60
5.10.4.1 US 60
5.10.4.2 Europe 60
5.10.4.3 Asia Pacific 61
5.10.5 IMPACT ON END USERS 61
5.10.5.1 Pharma & biopharma companies 61
5.10.5.2 Research & academia 61
5.10.5.3 Healthcare providers 62
5.10.5.4 Medical device companies 62
5.10.5.5 Other end users 62
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 63
6.1 KEY EMERGING TECHNOLOGIES 63
6.1.1 AI/ML AND SIMULATION MODELS 63
6.1.2 CLOUD COMPUTING AND HIGH-PERFORMANCE COMPUTING 64
6.1.3 DATA INTEGRATION PLATFORMS 64
6.2 COMPLEMENTARY TECHNOLOGIES 64
6.2.1 INTERNET OF MEDICAL THINGS (IOMT) AND CONNECTED DEVICES 65
6.2.2 MEDICAL IMAGING AND IMAGING AI 65
6.3 ADJACENT TECHNOLOGIES 65
6.3.1 CLINICAL DECISION SUPPORT SYSTEMS 66
6.3.2 AR/VR FOR SURGICAL SIMULATION AND TRAINING 66
6.4 TECHNOLOGY/PRODUCT ROADMAP 66
6.5 PATENT ANALYSIS 67
6.5.1 PATENT PUBLICATION TRENDS FOR DIGITAL TWIN IN HEALTHCARE MARKET 67
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 68
6.6 FUTURE APPLICATIONS 70
6.6.1 AI-DRIVEN PREDICTIVE MODELING AND CLINICAL DECISION SUPPORT 70
6.6.2 VIRTUAL THERAPEUTIC SIMULATION AND PERSONALIZED INTERVENTIONS 70
6.6.3 VIRTUAL CLINICAL TRIALS AND HEALTH SYSTEM OPTIMIZATION 71
6.6.4 POPULATION HEALTH MANAGEMENT AND PANDEMIC RESPONSE MODELING 71
6.7 IMPACT OF AI/GEN AI ON DIGITAL TWIN IN HEALTHCARE MARKET 71
6.7.1 INTRODUCTION 71
6.7.2 MARKET POTENTIAL OF AI/GEN AI IN DIGITAL TWIN IN HEALTHCARE MARKET 72
6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 73
6.7.3.1 AI-driven cardiac digital twin for personalized treatment planning 73
6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 74
6.7.4.1 Digital twin analytics & AI-driven simulation platforms 74
6.7.4.2 Digital twin platform integration & regulatory infrastructure 74
6.7.4.3 Clinical care, virtual monitoring & personalized therapeutics 75
6.7.5 USER READINESS AND IMPACT ASSESSMENT 75
6.7.5.1 User readiness 75
6.7.5.1.1 User A: Pharma & biopharma companies 75
6.7.5.1.2 User B: Research & academia 75
6.7.5.2 Impact assessment 76
6.7.5.2.1 User A: Pharma & biopharma companies 76
6.7.5.2.2 User B: Research & academia 76
7 REGULATORY LANDSCAPE 77
7.1 REGIONAL REGULATIONS AND COMPLIANCE 77
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
7.1.2 REGULATORY FRAMEWORK 80
7.1.2.1 North America 80
7.1.2.2 Europe 81
7.1.2.3 Asia Pacific 81
7.1.2.4 Latin America 82
7.1.2.5 Middle East & Africa 82
7.1.3 INDUSTRY STANDARDS 82
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 84
8.1 INTRODUCTION 84
8.2 DECISION-MAKING PROCESS 84
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 84
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
8.3.2 BUYING CRITERIA 86
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 87
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 87
8.5.1 UNMET NEEDS 87
8.5.2 END USER EXPECTATIONS 89
8.6 MARKET PROFITABILITY 89
9 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT 91
9.1 INTRODUCTION 92
9.2 SERVICES 92
9.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES 92
9.3 SOFTWARE 93
9.3.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH 93
10 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE 95
10.1 INTRODUCTION 96
10.2 PROCESS TWINS 96
10.2.1 RISING DEMAND FOR HEALTHCARE WORKFLOWS AND OPERATIONAL PROCESSES TO BOOST ADOPTION 96
10.3 SYSTEM TWINS 97
10.3.1 INCREASED DEMAND FOR OPERATIONAL EFFICIENCY IN HOSPITALS TO BOOST SEGMENT 97
10.4 WHOLE BODY TWINS 98
10.4.1 ADVANCEMENTS IN AI AND ML TECHNOLOGIES TO BOOST MARKET 98
10.5 BODY PART TWINS 99
10.5.1 RISING DEMAND FOR PERSONALIZED & PRECISION MEDICINE TO FUEL MARKET GROWTH 99
11 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION 101
11.1 INTRODUCTION 102
11.2 DRUG DISCOVERY & DEVELOPMENT 102
11.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY & DEVELOPMENT TO BOOST MARKET 102
11.3 PERSONALIZED MEDICINE 103
11.3.1 QUICK AND COST-EFFECTIVE DEVELOPMENT AND TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET 103
11.4 SURGICAL PLANNING & MEDICAL EDUCATION 104
11.4.1 ABILITY TO ENHANCE SURGICAL TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST ADOPTION 104
11.5 MEDICAL DEVICE DESIGN & TESTING 105
11.5.1 POTENTIAL OF DIGITAL TWINS TO STREAMLINE OPERATIONS, MINIMIZE RISK, AND REDUCE DOWNTIME TO PROMOTE USE 105
11.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT 106
11.6.1 IMPROVED EFFICIENCY AND VALUABLE INSIGHTS TO SUPPORT DEMAND 106
11.7 OTHER APPLICATIONS 107
12 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER 109
12.1 INTRODUCTION 110
12.2 PHARMA & BIOPHARMA COMPANIES 110
12.2.1 RISING DEMAND TO REDUCE TIME AND COST OF DRUG DEVELOPMENT TO BOOST ADOPTION 110
12.3 RESEARCH & ACADEMIA 111
12.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED BY DIGITAL TWINS TO BOOST ADOPTION 111
12.4 HEALTHCARE PROVIDERS 112
12.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH 112
12.5 MEDICAL DEVICE COMPANIES 113
12.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION OF MEDICAL DEVICES TO FUEL GROWTH 113
12.6 OTHER END USERS 114
?
13 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION 116
13.1 INTRODUCTION 117
13.2 NORTH AMERICA 117
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 118
13.2.2 US 120
13.2.2.1 Expanding applications of digital twins in healthcare to bolster market growth 120
13.2.3 CANADA 123
13.2.3.1 National digital health strategy and AI-driven clinical research accelerating adoption 123
13.3 EUROPE 125
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 126
13.3.2 GERMANY 128
13.3.2.1 Hospital digitalization mandates and engineering-healthcare convergence drive market 128
13.3.3 UK 130
13.3.3.1 NHS digital transformation and in silico trial leadership advances digital twin market 130
13.3.4 FRANCE 133
13.3.4.1 National AI health strategy and clinical research infrastructure support digital twin integration 133
13.3.5 ITALY 135
13.3.5.1 National recovery plan investments and clinical research modernization drive adoption 135
13.3.6 SPAIN 137
13.3.6.1 Health system digital transformation and biomedical research network enables digital twin growth 137
13.3.7 REST OF EUROPE 139
13.4 ASIA PACIFIC 141
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 142
13.4.2 JAPAN 144
13.4.2.1 National Digital Health Mission and pharma innovation ecosystem emerging as digital twin growth frontier 144
13.4.3 CHINA 147
13.4.3.1 National AI strategy and smart hospital infrastructure to drive large-scale digital twin deployment 147
13.4.4 INDIA 149
13.4.4.1 Improvement in healthcare infrastructure to support market growth 149
13.4.5 AUSTRALIA 151
13.4.5.1 National Digital Health Strategy 2023?2028 and Medical Research Future Fund advance digital twin adoption 151
13.4.6 SOUTH KOREA 153
13.4.6.1 Smart Hospital Policy and deep tech industrial ecosystem position country as regional leader 153
13.4.7 REST OF ASIA PACIFIC 155
13.5 LATIN AMERICA 157
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 158
13.5.2 BRAZIL 160
13.5.2.1 Country to dominate regional market 160
13.5.3 MEXICO 162
13.5.3.1 Favorable government strategies to drive market growth 162
13.5.4 REST OF LATIN AMERICA 164
13.6 MIDDLE EAST & AFRICA 166
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 167
13.6.2 GCC COUNTRIES 169
13.6.2.1 Increasing healthcare infrastructure development and investment to support market growth 169
13.6.2.2 Saudi Arabia 171
13.6.2.2.1 Government-led digital transformation and strong investments in AI-driven healthcare 171
13.6.2.3 UAE 173
13.6.2.3.1 Advancing digital health innovation and strategic collaborations to drive digital biomarkers adoption 173
13.6.2.4 Other GCC countries 175
13.6.2.4.1 Regulatory initiatives, national health visions, and digital health infrastructure driving digital biomarkers adoption 175
13.6.3 SOUTH AFRICA 177
13.6.3.1 Rising healthcare demand and need for cost-efficient, data-driven care delivery drive adoption 177
13.6.4 REST OF MIDDLE EAST & AFRICA 179
14 COMPETITIVE LANDSCAPE 182
14.1 OVERVIEW 182
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 182
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET 182
14.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 184
14.4 MARKET SHARE ANALYSIS, 2025 185
14.5 BRAND/PRODUCT COMPARISON 188
14.6 VALUATION & FINANCIAL METRICS 189
14.6.1 FINANCIAL METRICS 189
14.6.2 COMPANY VALUATION 189
14.7 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025 190
14.7.1 STARS 190
14.7.2 EMERGING LEADERS 190
14.7.3 PERVASIVE PLAYERS 190
14.7.4 PARTICIPANTS 190
?
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 192
14.7.5.1 Company footprint 192
14.7.5.2 Region footprint 192
14.7.5.3 Component footprint 193
14.7.5.4 Type footprint 194
14.7.5.5 Application footprint 194
14.7.5.6 End user footprint 195
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 196
14.8.1 PROGRESSIVE COMPANIES 196
14.8.2 RESPONSIVE COMPANIES 196
14.8.3 DYNAMIC COMPANIES 196
14.8.4 STARTING BLOCKS 196
14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 197
14.8.5.1 Detailed list of key startups/SME players 197
14.8.5.2 Competitive benchmarking of key startups/SMEs 198
14.9 COMPETITIVE SCENARIO 199
14.9.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS 199
14.9.2 DEALS 200
14.9.3 OTHER DEVELOPMENTS 201
15 COMPANY PROFILES 202
15.1 KEY PLAYERS 202
15.1.1 MICROSOFT 202
15.1.1.1 Business overview 202
15.1.1.2 Products/Services offered 203
15.1.1.3 Recent developments 204
15.1.1.3.1 Deals 204
15.1.1.4 MnM view 204
15.1.1.4.1 Key strengths 204
15.1.1.4.2 Strategic choices 204
15.1.1.4.3 Weaknesses & competitive threats 204
15.1.2 SIEMENS HEALTHINEERS AG 205
15.1.2.1 Business overview 205
15.1.2.2 Products/Services offered 206
15.1.2.3 Recent developments 207
15.1.2.3.1 Deals 207
15.1.2.4 MnM view 207
15.1.2.4.1 Key strengths 207
15.1.2.4.2 Strategic choices 208
15.1.2.4.3 Weaknesses & competitive threats 208
?
15.1.3 KONINKLIJKE PHILIPS N.V. 209
15.1.3.1 Business overview 209
15.1.3.2 Products/Services offered 210
15.1.3.3 Recent developments 211
15.1.3.3.1 Deals 211
15.1.3.4 MnM view 211
15.1.3.4.1 Key strengths 211
15.1.3.4.2 Strategic choices 211
15.1.3.4.3 Weaknesses & competitive threats 211
15.1.4 DASSAULT SYST?MES 212
15.1.4.1 Business overview 212
15.1.4.2 Products/Services offered 213
15.1.4.3 Recent developments 214
15.1.4.3.1 Product/Service launches & enhancements 214
15.1.4.3.2 Deals 215
15.1.4.4 MnM view 216
15.1.4.4.1 Key strengths 216
15.1.4.4.2 Strategic choices 216
15.1.4.4.3 Weaknesses & competitive threats 216
15.1.5 AMAZON WEB SERVICES, INC. 217
15.1.5.1 Business overview 217
15.1.5.2 Products/Services offered 218
15.1.5.3 Recent developments 219
15.1.5.3.1 Product/Service launches & enhancements 219
15.1.5.3.2 Deals 219
15.1.5.4 MnM view 219
15.1.5.4.1 Key strengths 219
15.1.5.4.2 Strategic choices 220
15.1.5.4.3 Weaknesses & competitive threats 220
15.1.6 GE HEALTHCARE 221
15.1.6.1 Business overview 221
15.1.6.2 Products/Services offered 222
15.1.6.3 Recent developments 223
15.1.6.3.1 Deals 223
15.1.7 ORACLE 224
15.1.7.1 Business overview 224
15.1.7.2 Products/Services offered 225
15.1.7.3 Recent developments 226
15.1.7.3.1 Deals 226
?
15.1.8 IBM 227
15.1.8.1 Business overview 227
15.1.8.2 Products/Services offered 228
15.1.8.3 Recent developments 229
15.1.8.3.1 Deals 229
15.1.9 PTC 230
15.1.9.1 Business overview 230
15.1.9.2 Products/Services offered 231
15.1.9.3 Recent developments 232
15.1.9.3.1 Deals 232
15.1.10 SAP 233
15.1.10.1 Business overview 233
15.1.10.2 Products/Services offered 234
15.1.10.3 Recent developments 235
15.1.10.3.1 Deals 235
15.1.10.3.2 Other developments 235
15.1.11 ATOS SE 236
15.1.11.1 Business overview 236
15.1.11.2 Products/Services offered 237
15.1.11.3 Recent developments 237
15.1.11.3.1 Deals 237
15.1.12 NVIDIA CORPORATION 238
15.1.12.1 Business overview 238
15.1.12.2 Products/Services offered 239
15.1.12.3 Recent developments 240
15.1.12.3.1 Product/Service launches & enhancements 240
15.1.12.3.2 Deals 240
15.1.13 ANSYS INC. 241
15.1.13.1 Business overview 241
15.1.13.2 Products/Services offered 242
15.1.13.3 Recent developments 243
15.1.13.3.1 Product/Service launches & enhancements 243
15.1.13.3.2 Deals 243
15.1.14 FASTSTREAM TECHNOLOGIES 244
15.1.14.1 Business overview 244
15.1.14.2 Products/Services offered 244
15.1.15 RESCALE, INC. 245
15.1.15.1 Business overview 245
15.1.15.2 Products/Services offered 245
15.1.15.2.1 Other developments 246
?
15.2 OTHER PLAYERS 247
15.2.1 TWIN HEALTH 247
15.2.2 VERTO HEALTH 248
15.2.3 QBIO 249
15.2.4 THOUGHTWIRE 250
15.2.5 SIM&CURE 251
15.2.6 OWKIN, INC 252
15.2.7 NUREA 253
15.2.8 UNLEARN.AI, INC. 254
15.2.9 VIRTONOMY GMBH 255
15.2.10 PREDISURGE 256
16 RESEARCH METHODOLOGY 257
16.1 RESEARCH APPROACH 257
16.1.1 SECONDARY RESEARCH 257
16.1.1.1 Key data from secondary sources 258
16.1.2 PRIMARY RESEARCH 258
16.1.2.1 Key data from primary sources 260
16.1.2.2 Breakdown of primaries 260
16.1.2.3 Insights from primary experts 261
16.2 RESEARCH METHODOLOGY DESIGN 261
16.3 MARKET SIZE ESTIMATION 262
16.4 MARKET BREAKDOWN DATA TRIANGULATION 266
16.5 MARKET SHARE ESTIMATION 267
16.6 STUDY ASSUMPTIONS 267
16.7 RESEARCH LIMITATIONS 268
16.7.1 METHODOLOGY-RELATED LIMITATIONS 268
16.7.2 SCOPE-RELATED LIMITATIONS 268
16.8 RISK ASSESSMENT 268
17 APPENDIX 269
17.1 DISCUSSION GUIDE 269
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 271
17.3 CUSTOMIZATION OPTIONS 273
17.4 RELATED REPORTS 273
17.5 AUTHOR DETAILS 274

ページTOPに戻る

List of Tables/Graphs

TABLE 1 DIGITAL TWINS IN HEALTHCARE MARKET: INCLUSIONS & EXCLUSIONS 28
TABLE 2 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 47
TABLE 3 DIGITAL TWIN IN HEALTHCARE MARKET: ROLE IN ECOSYSTEM 52
TABLE 4 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY TYPE (2025) 53
TABLE 5 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY REGION (2025) 54
TABLE 6 DIGITAL TWIN IN HEALTHCARE: KEY CONFERENCES & EVENTS, 2026?2027 55
TABLE 7 CASE 1: UNLEARN.AI ? DIGITAL TWIN SYNTHETIC CONTROL ARMS IN ALS CLINICAL TRIALS 57
TABLE 8 CASE 2: TWIN HEALTH ? WHOLE BODY DIGITAL TWIN FOR TYPE 2 DIABETES REMISSION 57
TABLE 9 CASE 3: INHEART/PREDISURGE ? AI-POWERED CARDIAC DIGITAL TWIN FOR SURGICAL PLANNING 58
TABLE 10 US ADJUSTED RECIPROCAL TARIFF RATES 59
TABLE 11 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR DIGITAL TWIN IN HEALTHCARE MARKET 68
TABLE 12 DIGITAL TWIN IN HEALTHCARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 69
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 18 REGULATORY SCENARIO IN NORTH AMERICA 80
TABLE 19 REGULATORY SCENARIO IN EUROPE 81
TABLE 20 REGULATORY SCENARIO IN ASIA PACIFIC 81
TABLE 21 REGULATORY SCENARIO IN LATIN AMERICA 82
TABLE 22 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 82
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE
END USERS (%) 85
TABLE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS 86
TABLE 25 UNMET NEEDS IN DIGITAL TWIN IN HEALTHCARE MARKET 88
TABLE 26 END USER EXPECTATIONS IN DIGITAL TWIN IN HEALTHCARE MARKET 89
TABLE 27 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 92
TABLE 28 DIGITAL TWINS IN HEALTHCARE SERVICES MARKET, BY REGION,
2024?2031 (USD MILLION) 93
TABLE 29 KEY SOFTWARE SOLUTIONS OFFERED BY PLAYERS 94
TABLE 30 DIGITAL TWINS IN HEALTHCARE SOFTWARE MARKET, BY REGION,
2024?2031 (USD MILLION) 94
TABLE 31 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024?2031 (USD MILLION) 96
TABLE 32 PROCESS TWINS OFFERED BY MARKET PLAYERS 96
TABLE 33 DIGITAL TWINS IN HEALTHCARE MARKET FOR PROCESS TWINS, BY REGION, 2024?2031 (USD MILLION) 97
TABLE 34 SYSTEM TWINS OFFERED BY MARKET PLAYERS 97
TABLE 35 DIGITAL TWINS IN HEALTHCARE MARKET FOR SYSTEM TWINS, BY REGION,
2024?2031 (USD MILLION) 98
TABLE 36 WHOLE BODY TWINS OFFERED BY MARKET PLAYERS 98
TABLE 37 DIGITAL TWINS IN HEALTHCARE MARKET FOR WHOLE BODY TWINS, BY REGION, 2024?2031 (USD MILLION) 99
TABLE 38 BODY PART TWINS OFFERED BY PLAYERS 100
TABLE 39 DIGITAL TWINS IN HEALTHCARE MARKET FOR BODY PART TWINS, BY REGION, 2024?2031 (USD MILLION) 100
TABLE 40 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 102
TABLE 41 DIGITAL TWINS IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024?2031 (USD MILLION) 103
TABLE 42 DIGITAL TWINS IN HEALTHCARE MARKET FOR PERSONALIZED MEDICINE,
BY REGION, 2024?2031 (USD MILLION) 104
TABLE 43 DIGITAL TWINS IN HEALTHCARE MARKET FOR SURGICAL PLANNING & MEDICAL EDUCATION, BY REGION, 2024?2031 (USD MILLION) 105
TABLE 44 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE DESIGN & TESTING, BY COUNTRY, 2024?2031 (USD MILLION) 106
TABLE 45 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT, BY COUNTRY, 2024?2031 (USD MILLION) 107
TABLE 46 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 108
TABLE 47 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 110
TABLE 48 DIGITAL TWINS IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY REGION, 2024?2031 (USD MILLION) 111
TABLE 49 DIGITAL TWINS IN HEALTHCARE MARKET FOR RESEARCH & ACADEMIA,
BY REGION, 2024?2031 (USD MILLION) 112
TABLE 50 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2024?2031 (USD MILLION) 113
TABLE 51 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE COMPANIES,
BY REGION, 2024?2031 (USD MILLION) 114
TABLE 52 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2024?2031 (USD MILLION) 115
TABLE 53 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION, 2024?2031 (USD MILLION) 117
TABLE 54 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 119
TABLE 55 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 119
TABLE 56 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 119
TABLE 57 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 120
TABLE 58 NORTH AMERICA: DIGITAL TWINS IN MARKET, BY END USER,
2024?2031 (USD MILLION) 120
TABLE 59 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 122
TABLE 60 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 122
TABLE 61 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 122
TABLE 62 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 123
TABLE 63 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 124
TABLE 64 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 124
TABLE 65 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 125
TABLE 66 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 125
TABLE 67 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 126
TABLE 68 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 126
TABLE 69 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 127
TABLE 70 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 127
TABLE 71 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 128
TABLE 72 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 129
TABLE 73 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 129
TABLE 74 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 130
TABLE 75 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 130
TABLE 76 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 131
TABLE 77 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 132
TABLE 78 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 132
TABLE 79 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 132
TABLE 80 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 133
TABLE 81 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 134
TABLE 82 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 134
TABLE 83 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 135
TABLE 84 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 136
TABLE 85 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 136
TABLE 86 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 136
TABLE 87 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 137
TABLE 88 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 137
TABLE 89 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 138
TABLE 90 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 138
TABLE 91 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 139
TABLE 92 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 140
TABLE 93 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 140
TABLE 94 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 140
TABLE 95 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024?2031 (USD MILLION) 141
TABLE 96 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 143
TABLE 97 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 143
TABLE 98 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 143
TABLE 99 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 144
TABLE 100 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 144
TABLE 101 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 145
TABLE 102 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 146
TABLE 103 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 146
TABLE 104 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 147
TABLE 105 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 148
TABLE 106 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 148
TABLE 107 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 148
TABLE 108 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 149
TABLE 109 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 150
TABLE 110 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 150
TABLE 111 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 150
TABLE 112 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 151
TABLE 113 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 152
TABLE 114 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 152
TABLE 115 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 152
TABLE 116 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 153
TABLE 117 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 154
TABLE 118 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 154
TABLE 119 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 155
TABLE 120 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 155
TABLE 121 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 156
TABLE 122 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 156
TABLE 123 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 157
TABLE 124 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024?2031 (USD MILLION) 157
TABLE 125 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 158
TABLE 126 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 158
TABLE 127 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 159
TABLE 128 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 159
TABLE 129 LATIN AMERICA: DIGITAL TWINS IN MARKET, BY END USER,
2024?2031 (USD MILLION) 160
TABLE 130 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 161
TABLE 131 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 161
TABLE 132 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 161
TABLE 133 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 162
TABLE 134 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 163
TABLE 135 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 163
TABLE 136 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 163
TABLE 137 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 164
TABLE 138 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 165
TABLE 139 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024?2031 (USD MILLION) 165
TABLE 140 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 165
TABLE 141 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024?2031 (USD MILLION) 166
TABLE 142 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 167
TABLE 143 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 167
TABLE 144 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024?2031 (USD MILLION) 168
TABLE 145 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 168
TABLE 146 MIDDLE EAST & AFRICA: DIGITAL TWINS IN MARKET, BY END USER,
2024?2031 (USD MILLION) 169
TABLE 147 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 170
TABLE 148 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024?2031 (USD MILLION) 170
TABLE 149 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 170
TABLE 150 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 171
TABLE 151 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 171
TABLE 152 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 172
TABLE 153 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 172
TABLE 154 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 173
TABLE 155 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 173
TABLE 156 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 174
TABLE 157 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 174
TABLE 158 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 175
TABLE 159 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 175
TABLE 160 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 176
TABLE 161 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024?2031 (USD MILLION) 176
TABLE 162 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 177
TABLE 163 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024?2031 (USD MILLION) 177
TABLE 164 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2024?2031 (USD MILLION) 178
TABLE 165 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2024?2031 (USD MILLION) 178
TABLE 166 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 179
TABLE 167 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2024?2031 (USD MILLION) 179
TABLE 168 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT, 2024?2031 (USD MILLION) 180
TABLE 169 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY TYPE, 2024?2031 (USD MILLION) 180
TABLE 170 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 181
TABLE 171 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY END USER, 2024?2031 (USD MILLION) 181
TABLE 172 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET, JANUARY 2023?MAY 2026 182
TABLE 173 DIGITAL TWINS IN HEALTHCARE MARKET: DEGREE OF COMPETITION 186
TABLE 174 DIGITAL TWIN IN HEALTHCARE MARKET: REGION FOOTPRINT (15 COMPANIES) 192
TABLE 175 DIGITAL TWIN IN HEALTHCARE MARKET: COMPONENT FOOTPRINT
(15 COMPANIES) 193
TABLE 176 DIGITAL TWIN IN HEALTHCARE MARKET: TYPE FOOTPRINT (15 COMPANIES) 194
TABLE 177 DIGITAL TWIN IN HEALTHCARE MARKET: APPLICATION FOOTPRINT
(15 COMPANIES) 194
TABLE 178 DIGITAL TWIN IN HEALTHCARE MARKET: END USER FOOTPRINT (15 COMPANIES) 195
TABLE 179 DIGITAL TWINS IN HEALTHCARE MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2023?MAY 2026 199
TABLE 180 DIGITAL TWINS IN HEALTHCARE MARKET: DEALS, JANUARY 2023?MAY 2026 200
TABLE 181 DIGITAL TWINS IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2023?MAY 2026 201
TABLE 182 MICROSOFT: COMPANY OVERVIEW 202
TABLE 183 MICROSOFT CORPORATION: PRODUCTS/SERVICES OFFERED 203
TABLE 184 MICROSOFT: DEALS, JANUARY 2023?MAY 2026 204
TABLE 185 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 205
TABLE 186 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 206
TABLE 187 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023?MAY 2026 207
TABLE 188 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 209
TABLE 189 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 210
TABLE 190 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023?MAY 2026 211
TABLE 191 DASSAULT SYST?MES: COMPANY OVERVIEW 212
TABLE 192 DASSAULT SYST?MES: PRODUCTS/SERVICES OFFERED 213
TABLE 193 DASSAULT SYST?MES: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023?MAY 2026 214
TABLE 194 DASSAULT SYST?MES: DEALS, JANUARY 2023?MAY 2026 215
TABLE 195 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW 217
TABLE 196 AMAZON WEB SERVICES, INC.: PRODUCTS/SERVICES OFFERED 218
TABLE 197 AMAZON WEB SERVICES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023?MAY 2026 219
TABLE 198 AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2023?MAY 2026 219
TABLE 199 GE HEALTHCARE: COMPANY OVERVIEW 221
TABLE 200 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 222
TABLE 201 GE HEALTHCARE: DEALS, JANUARY 2023?MAY 2026 223
TABLE 202 ORACLE: COMPANY OVERVIEW 224
TABLE 203 ORACLE: PRODUCTS/SERVICES OFFERED 225
TABLE 204 ORACLE: DEALS, JANUARY 2023?MAY 2026 226
TABLE 205 IBM: COMPANY OVERVIEW 227
TABLE 206 IBM: PRODUCTS/SERVICES OFFERED 228
TABLE 207 IBM: DEALS, JANUARY 2023?MAY 2026 229
TABLE 208 PTC: COMPANY OVERVIEW 230
TABLE 209 PTC: PRODUCTS/SERVICES OFFERED 231
TABLE 210 PTC: DEALS, JANUARY 2023?MAY 2026 232
TABLE 211 SAP: COMPANY OVERVIEW 233
TABLE 212 SAP: PRODUCTS/SERVICES OFFERED 234
TABLE 213 SAP: DEALS, JANUARY 2023?MAY 2026 235
TABLE 214 SAP: OTHER DEVELOPMENTS, JANUARY 2023?MAY 2026 235
TABLE 215 ATOS SE: COMPANY OVERVIEW 236
TABLE 216 ATOS SE: PRODUCTS/SERVICES OFFERED 237
TABLE 217 ATOS SE: DEALS, JANUARY 2023?MAY 2026 237
TABLE 218 NVIDIA CORPORATION: COMPANY OVERVIEW 238
TABLE 219 NVIDIA CORPORATION: PRODUCTS/SERVICES OFFERED 239
TABLE 220 NVIDIA CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023?MAY 2026 240
TABLE 221 NVIDIA CORPORATION: DEALS, JANUARY 2023?MAY 2026 240
TABLE 222 ANSYS INC.: COMPANY OVERVIEW 241
TABLE 223 ANSYS INC.: PRODUCTS/SERVICES OFFERED 242
TABLE 224 ANSYS INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS,
JANUARY 2023?MAY 2026 243
TABLE 225 ANSYS INC.: DEALS, JANUARY 2023?MAY 2026 243
TABLE 226 FASTSTREAM TECHNOLOGIES: COMPANY OVERVIEW 244
TABLE 227 FASTSTREAM TECHNOLOGIES: PRODUCTS/SERVICES OFFERED 244
TABLE 228 RESCALE, INC.: COMPANY OVERVIEW 245
TABLE 229 RESCALE, INC.: PRODUCTS/SERVICES OFFERED 245
TABLE 230 RESCALE, INC.: OTHER DEVELOPMENTS, JANUARY 2023?MAY 2026 246
TABLE 231 TWIN HEALTH: COMPANY OVERVIEW 247
TABLE 232 VERTO HEALTH: COMPANY OVERVIEW 248
TABLE 233 QBIO: COMPANY OVERVIEW 249
TABLE 234 THOUGHTWIRE: COMPANY OVERVIEW 250
TABLE 235 SIM&CURE: COMPANY OVERVIEW 251
TABLE 236 OWKIN, INC: COMPANY OVERVIEW 252
TABLE 237 NUREA: COMPANY OVERVIEW 253
TABLE 238 UNLEARN.AI, INC.: COMPANY OVERVIEW 254
TABLE 239 VIRTONOMY GMBH: COMPANY OVERVIEW 255
TABLE 240 PREDISURGE: COMPANY OVERVIEW 256
TABLE 241 DIGITAL TWINS IN HEALTHCARE MARKET: RISK ASSESSMENT 268FIGURE 1 DIGITAL TWINS IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE 28
FIGURE 2 DIGITAL TWINS IN HEALTHCARE MARKET: YEARS CONSIDERED 29
FIGURE 3 MARKET SCENARIO 31
FIGURE 4 GLOBAL DIGITAL TWINS IN HEALTHCARE MARKET, 2024?2031 32
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWIN IN HEALTHCARE MARKET, 2023?2026 32
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF DIGITAL TWIN IN HEALTHCARE MARKET 33
FIGURE 7 HIGH-GROWTH SEGMENTS IN DIGITAL TWIN IN HEALTHCARE MARKET,
2026?2031 34
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN DIGITAL TWIN IN HEALTHCARE MARKET DURING FORECAST PERIOD 35
FIGURE 9 INCREASING USE OF DIGITAL TWINS AND GROWING IMPORTANCE OF PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH 36
FIGURE 10 SOFTWARE ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA
IN 2025 37
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 37
FIGURE 12 DIGITAL TWIN IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 46
FIGURE 13 DIGITAL TWIN IN MARKET: VALUE CHAIN ANALYSIS (2025) 50
FIGURE 14 DIGITAL TWIN IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 52
FIGURE 15 REVENUE SHIFT IN DIGITAL TWIN IN HEALTHCARE MARKET 56
FIGURE 16 RECENT FUNDING OF PLAYERS IN DIGITAL TWIN IN HEALTHCARE MARKET 56
FIGURE 17 PATENT PUBLICATION TRENDS IN DIGITAL TWIN IN HEALTHCARE MARKET,
2015?2026 68
FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR DIGITAL TWIN IN HEALTHCARE MARKET 68
FIGURE 19 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DIGITAL TWIN IN HEALTHCARE MARKET (JANUARY 2015 TO FEBRUARY 2026) 69
FIGURE 20 MARKET POTENTIAL OF AI/GEN AI ON DIGITAL TWIN IN HEALTHCARE ACROSS INDUSTRIES 72
FIGURE 21 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 74
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 85
FIGURE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS 86
FIGURE 24 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 118
FIGURE 25 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 142
FIGURE 26 DIGITAL TWIN IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS 185
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE (2025) 186
FIGURE 28 DIGITAL TWIN IN HEALTHCARE MARKET: BRAND COMPARATIVE ANALYSIS 188
FIGURE 29 EV/EBITDA OF KEY VENDORS 189
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 189
FIGURE 31 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 191
FIGURE 32 DIGITAL TWIN IN HEALTHCARE MARKET: COMPANY FOOTPRINT 192
FIGURE 33 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 197
FIGURE 34 MICROSOFT: COMPANY SNAPSHOT (2025) 203
FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 206
FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 210
FIGURE 37 DASSAULT SYST?MES: COMPANY SNAPSHOT (2025) 213
FIGURE 38 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2025) 218
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 222
FIGURE 40 ORACLE: COMPANY SNAPSHOT (2024) 225
FIGURE 41 IBM: COMPANY SNAPSHOT (2025) 228
FIGURE 42 PTC: COMPANY SNAPSHOT (2025) 231
FIGURE 43 SAP: COMPANY SNAPSHOT (2025) 234
FIGURE 44 ATOS SE: COMPANY SNAPSHOT (2025) 236
FIGURE 45 NVIDIA CORPORATION: COMPANY SNAPSHOT (2025) 239
FIGURE 46 ANSYS INC. (SYNOPSYS, INC.): COMPANY SNAPSHOT (2025) 242
FIGURE 47 RESEARCH DESIGN 257
FIGURE 48 PRIMARY SOURCES 259
FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 260
FIGURE 50 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 262
FIGURE 51 BOTTOM-UP APPROACH 263
FIGURE 52 TOP-DOWN APPROACH 263
FIGURE 53 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS 264
FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 265
FIGURE 55 DIGITAL TWINS IN HEALTHCARE MARKET: DATA TRIANGULATION 266